Saltar al contenido
Merck

Sustained lung inflation at birth for preterm infants: a randomized clinical trial.

Pediatrics (2015-01-28)
Gianluca Lista, Luca Boni, Fabio Scopesi, Fabio Mosca, Daniele Trevisanuto, Hubert Messner, Giovanni Vento, Rosario Magaldi, Antonio Del Vecchio, Massimo Agosti, Camilla Gizzi, Fabrizio Sandri, Paolo Biban, Massimo Bellettato, Diego Gazzolo, Antonio Boldrini, Carlo Dani
RESUMEN

Studies suggest that giving newly born preterm infants sustained lung inflation (SLI) may decrease their need for mechanical ventilation (MV) and improve their respiratory outcomes. We randomly assigned infants born at 25 weeks 0 days to 28 weeks 6 days of gestation to receive SLI (25 cm H2O for 15 seconds) followed by nasal continuous positive airway pressure (nCPAP) or nCPAP alone in the delivery room. SLI and nCPAP were delivered by using a neonatal mask and a T-piece ventilator. The primary end point was the need for MV in the first 72 hours of life. The secondary end points included the need for respiratory supports and survival without bronchopulmonary dysplasia (BPD). A total of 148 infants were enrolled in the SLI group and 143 in the control group. Significantly fewer infants were ventilated in the first 72 hours of life in the SLI group (79 of 148 [53%]) than in the control group (93 of 143 [65%]); unadjusted odds ratio: 0.62 [95% confidence interval: 0.38-0.99]; P = .04). The need for respiratory support and survival without BPD did not differ between the groups. Pneumothorax occurred in 1% (n = 2) of infants in the control group compared with 6% (n = 9) in the SLI group, with an unadjusted odds ratio of 4.57 (95% confidence interval: 0.97-21.50; P = .06). SLI followed by nCPAP in the delivery room decreased the need for MV in the first 72 hours of life in preterm infants at high risk of respiratory distress syndrome compared with nCPAP alone but did not decrease the need for respiratory support and the occurrence of BPD.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Agua, suitable for HPLC
Sigma-Aldrich
Agua, Nuclease-Free Water, for Molecular Biology
Sigma-Aldrich
Agua, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Agua, Deionized
Sigma-Aldrich
Agua, for embryo transfer, sterile-filtered, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Agua, for molecular biology, sterile filtered
Supelco
Agua, suitable for ion chromatography
Sigma-Aldrich
Agua, BioPerformance Certified
Sigma-Aldrich
Agua, ACS reagent
Supelco
Agua, ACS reagent, for ultratrace analysis
Supelco
Agua, for TOC analysis
Sigma-Aldrich
Agua, for cell biology, sterile ultrafiltered
Agua, UKAS ISO/IEC17025 and ISO Guide 34 certified, density: 0.9982 g/mL at 20 °C, density: 0.9970 g/mL at 25 °C
Sigma-Aldrich
Agua, PCR Reagent
Sigma-Aldrich
Water, deuterium-depleted, ≤1 ppm (Deuterium oxide)
Sigma-Aldrich
Water-16O, ≥99.94 atom % 16O
Sigma-Aldrich
Agua, endotoxin, free
Supelco
Agua, for HPCE, for luminescence, suitable for UV/Vis spectroscopy
Sigma-Aldrich
Agua, tested according to Ph. Eur.
Agua, UKAS ISO/IEC17025 and ISO Guide 34 certified, density: 0.9982 g/mL at 20 °C, density: 0.9970 g/mL at 25 °C
Supelco
Agua, H&D Fitzgerald Ltd. Quality